CD40 and neoplasm: Agonists to CD40 (CD40a) can trigger pro-inflammatory cytokine secretion and promote maturation and activation of macrophages and other antigen presenting cells to enhance anti-tumor activity, stimulate antigen presentation to T cells and promote influx of cytotoxic T cells [122].